NCT05745181View on ClinicalTrials.gov

Clinical Study of Anti-CD1a CAR-T in the Treatment of R/R Acute T-lymphoblastic Leukemia/Lymphoblastic Lymphoma

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions

Acute T-lymphoblastic LeukemiaAcute T-lymphoblastic Lymphoma

Interventions

BIOLOGICAL

CAR-T Cell Infusion

Peripheral blood mononuclear cells were isolated, amplified and cultured in vitro, pretreated with FC regimen, and Anti-CD1a CAR-T cells were transfused.

Trial Locations (1)

221002

RECRUITING

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

All Listed Sponsors

lead

The Affiliated Hospital of Xuzhou Medical University

OTHER